Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Butow P., Coates A., Dunn S., Bernhard J., Hürny C. On the receiving end. IV: Validation of quality of life indicators. Ann Oncol. 1991 Sep;2(8):597–603. doi: 10.1093/oxfordjournals.annonc.a058027. [DOI] [PubMed] [Google Scholar]
- Clark A., Fallowfield L. J. Quality of life measurements in patients with malignant disease: a review. J R Soc Med. 1986 Mar;79(3):165–169. doi: 10.1177/014107688607900311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coates A., Gebski V., Bishop J. F., Jeal P. N., Woods R. L., Snyder R., Tattersall M. H., Byrne M., Harvey V., Gill G. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med. 1987 Dec 10;317(24):1490–1495. doi: 10.1056/NEJM198712103172402. [DOI] [PubMed] [Google Scholar]
- De Vita V. T., Jr Breast cancer therapy: exercising all our options. N Engl J Med. 1989 Feb 23;320(8):527–529. doi: 10.1056/NEJM198902233200812. [DOI] [PubMed] [Google Scholar]
- Donovan K., Sanson-Fisher R. W., Redman S. Measuring quality of life in cancer patients. J Clin Oncol. 1989 Jul;7(7):959–968. doi: 10.1200/JCO.1989.7.7.959. [DOI] [PubMed] [Google Scholar]
- Goldhirsch A., Gelber R. D., Simes R. J., Glasziou P., Coates A. S. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol. 1989 Jan;7(1):36–44. doi: 10.1200/JCO.1989.7.1.36. [DOI] [PubMed] [Google Scholar]
- Jachuck S. J., Brierley H., Jachuck S., Willcox P. M. The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract. 1982 Feb;32(235):103–105. [PMC free article] [PubMed] [Google Scholar]
- Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991 Mar 14;324(11):709–715. doi: 10.1056/NEJM199103143241101. [DOI] [PubMed] [Google Scholar]
- Mackillop W. J., Ward G. K., O'Sullivan B. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer. 1986 Oct;54(4):661–667. doi: 10.1038/bjc.1986.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGuire W. L. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):525–527. doi: 10.1056/NEJM198902233200811. [DOI] [PubMed] [Google Scholar]
- Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Goodman P. J., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352–358. doi: 10.1056/NEJM199002083220602. [DOI] [PubMed] [Google Scholar]
- Moinpour C. M., Feigl P., Metch B., Hayden K. A., Meyskens F. L., Jr, Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst. 1989 Apr 5;81(7):485–495. doi: 10.1093/jnci/81.7.485. [DOI] [PubMed] [Google Scholar]
- Poon M. A., O'Connell M. J., Moertel C. G., Wieand H. S., Cullinan S. A., Everson L. K., Krook J. E., Mailliard J. A., Laurie J. A., Tschetter L. K. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989 Oct;7(10):1407–1418. doi: 10.1200/JCO.1989.7.10.1407. [DOI] [PubMed] [Google Scholar]
- Rapp E., Pater J. L., Willan A., Cormier Y., Murray N., Evans W. K., Hodson D. I., Clark D. A., Feld R., Arnold A. M. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol. 1988 Apr;6(4):633–641. doi: 10.1200/JCO.1988.6.4.633. [DOI] [PubMed] [Google Scholar]